A case of circulatory collapse during intravenous immunoglobulin therapy: A manageable adverse effect!

Anaesth Crit Care Pain Med. 2015 Apr;34(2):113-4. doi: 10.1016/j.accpm.2014.08.004. Epub 2015 Apr 7.

Authors

Nicolas Charhon¹, Aurélie Bonnet², Zoé Schmitt², Bruno Charpiat³

Affiliations

¹ Department of pharmacy, Hôpital de la Croix-Rousse, Hospices Civils de Lyon, 103, grande rue de la Croix-Rousse, Lyon 69004, France. Electronic address: nicolas.charhon@chu-lyon.fr.
² Department of Anesthesiology and Critical Care, Hôpital de la Croix Rousse, Hospices Civils de Lyon, Lyon 69004, France.
³ Department of pharmacy, Hôpital de la Croix-Rousse, Hospices Civils de Lyon, 103, grande rue de la Croix-Rousse, Lyon 69004, France.

PMID: 25858620
DOI: 10.1016/j.accpm.2014.08.004

No abstract available

Keywords: Intravenous immunoglobulin; Off-label use; Shock.

Publication types

Case Reports
Letter

MeSH terms

Female
Humans
Immunoglobulins, Intravenous / adverse effects*
Middle Aged
Shock / chemically induced*
Shock / prevention & control

Substances

Immunoglobulins, Intravenous